Merkel Cell Carcinoma (MCC) is an uncommon, highly aggressive skin malignancy that develops usually in sun-exposed areas, most common on the head and neck area (55%). MCC is mainly
Merkel carcinoma is very rare skin cancer, with high mortality. The standard treatment until 2017 was surgery, radiotherapy, and chemotherapy. Since 2017 FDA and EC approved Avelumab for the marketing ... trial. In…
series and critical review of the current understanding and guidelines in management of Merkel cell carcinoma are presented. Merkel Cell Carcinoma of the head and neck is highly aggressive ... short to long term…
tubes not lined by endothelial cells, and this phenomenon was termed vasculogenic mimicry. Merkel cell carcinoma is a very aggressive but rare form of skin cancer, of neuroendocrine origin ... with increasing incidence…
Merkel cell carcinoma (MCC) may be a rare, aggressive sort of carcinoma with a high risk for returning (recurring) and spreading (metastasizing), often within 2 to 3 years after initial ... Merkel cell polyomavirus…
Merkel Cell Carcinoma (MCC) is a rare and invasive cutaneous neuroendocrine tumor with a mortality rate of about 25%. Accurate assessment of lymph node involvement in patients with MCC significantly ... increasing use…
Context :Merkel cell carcinoma is an aggressive cutaneous tumor without clearly defined treatment and high propensity for metastasis. Case report :This case describes a sixty four year old presenting with…
release various neurotransmitters to nerve endings. Tumor arising from Merkel cells called Merkel cell carcinoma (MCC). This highly aggressive malignancy occurs most often in the elderly white peoples
Merkel Cell Carcinoma (MCC) is a rare but highly malignant skin tumor of neuroendocrine origin. MCC is a highly metastatic cancer with a very fast rate of progression. Its metastatic
Merkel Cell Carcinoma (MCC) is a rare but aggressive skin cancer. Similar to melanoma, infiltration of CD8+ T cells is associated with an improved prognosis, which provides rationale for immunotherapy
Merkel-Cell Carcinoma (MCC) is rare and highly aggressive skin cancer, usually due to Merckel-cell polyomavirus. Venous ulcers are full-thickness defects of skin in the lower limb when
Merkel Cell Carcinoma (MCC) is an aggressive neuroendocrine cancer of the skin. The incidence has been quadrupled with a 5-year mortality rate of 46%, presently there is no cure ... metastatic disease. Despite the…
Merkel cell carcinoma (MCC) is an uncommon neuroendocrine tumor that represents a small percentage of skin malignancies, with an aggressive behavior and survival rate at 5 years
Context Merkel cell carcinoma is a rare skin tumour which can metastasise to regional lymph nodes and occasionally todistant organs. Merkel cell carcinoma metastasis to the pancreas has been rarely ... reported. Case…
Merkel Cell Carcinoma (MCC) is a rare, malignant neuroendocrine tumour belonging to the broad category of cancers called small round blue cell tumours. We present a case of this rare
Merkel Cell Carcinoma (MCC) is a rare, highly aggressive neuroendocrine skin cancer. Risk factors for MCC include age >65 years, immunosuppression, sun exposure and infection by polyomavirus. This neuroendocrine skin
Introduction: Metastatic Merkel Cell Carcinoma (MCC) is characterized by poor prognosis and poor response to cytotoxic chemotherapy. Immune Checkpoint Inhibitors (ICIs) were evaluated in several clinical trials…
associated malignancies have identifiable non-cellular targets that make them valuable systems. Merkel cell carcinoma: Merkel cell polyoma virus (MCV) causes a rare, lethal skin cancer called Merkel cell carcinoma
have been accounted for in number of disease, for example, leukemia, burkits lymphoma, Merkel cell carcinoma, cervical malignancy, Hodgkin's lymphoma, post-transplant lymphoma, nasopharyngeal carcinoma, Kaposi's…
well as high neoantigen content. In this subgroup of cases and those with Merkel Carcinoma and Hodgkin lymphoma, ORRs of CPB can be in the range of 50â??80%. Furthermore
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.